InnoCare Optoelectronics (TPE:6861) Research & Development: NT$219 Mil (TTM As of Dec. 2025)


TPE:6861 InnoCare Optoelectronics Corp TPE:6861
66 GF Score
Price NT$303.00
GF Value NT$85.66
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is InnoCare Optoelectronics Research & Development?

InnoCare Optoelectronics TPE:6861 -9.15% 66 Research & Development is NT$219 Mil as of Dec. 2025. GuruFocus rates TPE:6861 with a GF Score™ of 66/100 and a GF Value™ of NT$85.66 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. InnoCare Optoelectronics's Research & Development for the three months ended in Dec. 2025 was NT$56 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$219 Mil.

InnoCare Optoelectronics  (TPE:6861) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

InnoCare Optoelectronics Research & Development Related Terms

InnoCare Optoelectronics Research & Development Historical Data

* Premium members only.

The historical data trend for InnoCare Optoelectronics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InnoCare Optoelectronics Research & Development Chart

InnoCare Optoelectronics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 239.67 248.44 228.28 275.04 218.94

InnoCare Optoelectronics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.99 56.16 54.02 52.35 56.41
TPE:6861
66GF Score
InnoCare Optoelectronics Corp TPE:6861
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InnoCare Optoelectronics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$219 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$219 Mil mean?
InnoCare Optoelectronics (TPE:6861) has a Research & Development of NT$219 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on InnoCare Optoelectronics and its competitors.
Is InnoCare Optoelectronics' Research & Development too high?
InnoCare Optoelectronics' current Research & Development is NT$219 Mil. Overall, InnoCare Optoelectronics has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' Research & Development compare to ABT and SYK?
InnoCare Optoelectronics' Research & Development of NT$219 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on InnoCare Optoelectronics and its competitors. InnoCare Optoelectronics's current Research & Development is NT$219 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$85.66, compared to a current price of NT$303.00 — trading 253.7% above its estimated fair value. The current Research & Development is NT$219 Mil. InnoCare Optoelectronics' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current Research & Development is NT$219 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?

Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued. The current stock price of NT$303.00 is trading 253.7% above its estimated GF Value™ of NT$85.66. GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.

Key valuation signals for TPE:6861:

  • Research & Development: NT$219 Mil
  • GF Value™: NT$85.66 vs. price of NT$303.00 (253.7% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InnoCare Optoelectronics Business Description

Address Huanxi Road, Room B, No. 2, Section 2, Southern Science Park, Xincheng District, Tainan, TWN, 17571
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
66GF Score

Get the complete analysis for TPE:6861

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$303.00
Price
NT$85.66
GF Value